Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wicket Gaming AB (publ) carries out a directed issue of shares of approximately SEK 5 million and raises a loan of SEK 15 million

Wicket Gaming AB (publ) (“Wicket Gaming” or the “Company”) has, with the support of the authorization from the Annual General Meeting on March 16, 2021, completed a directed issue of 277,778 shares (the “Directed Issue”) to a strategic investor. The subscription price amounted to SEK 18 per share, which corresponds to a discount of approximately 9 percent comparison to the closing price on May 24, 2022. The company will receive approximately SEK 5 million through the Directed Issue. In connection with the Directed Issue, the Board of Directors proposes, subject to the support of the

Nordea Bank Abp: Repurchase of own shares on 25.05.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares25.05.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 25.05.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XSTO 154,392 9.55 1,473,997.60XHEL 106,601 9.60 1,023,881.28CEUX 206,292 9.58 1,976,984.55AQEU 26,088 9.60 250,459.91

Annual General Meeting held

The Annual General Meeting (AGM) of Bonheur ASA was held today, Wednesday 25 May 2022. All items on the agenda, which had been sent to Oslo Stock Exchange on 4 May 2022, were resolved in accordance with the corresponding proposals placed before the AGM. The Vice Chairman of the Shareholders' Committee, Einar Harboe, chaired the AGM. The Chairman of the Board, Fred. Olsen, was present. The Managing Director of Bonheur, Anette S. Olsen, and Bonheur's auditor, Øyvind Skorgevik from KPMG, were also present at the meeting. The AGM approved the financial statements and annual report of

Everfuel: Mandatory notification of trade by primary insider

Herning, Denmark, 25 May 2022 – Søren Eriksen, Chair of Board of Directors of Everfuel A/S, has today purchased 6,091 shares in Everfuel A/S at an average price of NOK 58,31 per share. Following this, Eriksen holds a total of 6,091 shares in Everfuel.  For additional information, please contact: Anders Bertelsen, CFO, +45 21 35 43 03, ab@everfuel.com About Everfuel | www.everfuel.com Everfuel is making green hydrogen for zero emission mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply- and fueling solutions. We own and operate

Norway Royal Salmon ASA (NRS): CFO Ola Loe steps down

(Trondheim, 25 May 2022) Ola Loe steps down from his position as CFO of Norway Royal Salmon ASA ("NRS") after 13 years in the company. He will for a transitional period remain available for the board and management team of NRS. "Ola has done a solid job for NRS and he has played an important role in the development of the company since he took the position as CFO in 2009. I would like to thank Ola for his commitment and wish him the best of luck in the future, says Charles Høstlund  - Interim CEO in NRS. "NRS has had a fantastic development from 2009. From an annual harvest volume of

TikoMed AB reports positive phase II clinical data for the treatment of Amyothropic Lateral Sclerosis in data published by PLOS ONE

Viken – 25th May, 2022 – A new study with TikoMed’s platform lead clinical drug candidate ILB®\,\[ ]provides positive safety and tolerability results and the first clinical evidence of encouraging clinical efficacy of ILB® in the treatment of amyotrophic lateral sclerosis (ALS). The study was published in PLOS ONE today. In a Phase II study of ILB® administered to patients with ALS for five weeks, the progression of ALS was halted and/or reversed for all study participants assessed using the validated ALSFRS-R and Norris clincal rating scales that score a broad range of patient relevant

Endomines resolves on a directed issue of convertibles to LDA Capital Limited

Endomines AB (publ), Stock Exchange Release 25 May 2022 at 18:00 CEST   The Board of Directors of Endomines AB (publ) ("Endomines" or the "Company") has, based on the authorisation granted by the Annual General Meeting on 10 June 2021, resolved on a directed issue of convertibles with a total nominal amount of EUR 600,000 (corresponding to SEK 6,288,720[1]) to LDA Capital Limited ("LDA") (the “Directed Issue”), providing total issue proceeds of EUR 600,000.   The Directed Issue is carried out as part of the financing package which Endomines has entered into with LDA, which was

Modus Therapeutics Updates on Sevuparin Phase 1b Clinical Trial Timelines

STOCKHOLM, SWEDEN – 25 May 2022: Modus Therapeutics Holding AB, a biopharma company focused on the clinical development of its proprietary asset sevuparin for the treatment of sepsis/septic shock and other conditions with systemic inflammation, provides an update on its ongoing Phase 1b LPS-challenge study and its other clinical activities with sevuparin.Modus has observed that the ongoing effects of the Covid-19 pandemic throughout spring have slowed down enrolment for the Phase 1b trial, causing a delay to the anticipated timelines. This is largely attributed to subjects being unable to

Notice of the Annual General Meeting in Realfiction Holding AB (publ)

The shareholders of Realfiction Holding AB (publ), reg. no 559110-4616 (”the Company”) are hereby summoned to the Annual General Meeting on Monday, 27 June 2022. The Annual General Meeting will be carried out through advance voting (postal voting) only pursuant to temporary legislation and the Company welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting according to the procedure set out below. Information on the resolutions passed at the Annual General Meeting will be published on 27 June 2022, as soon as the result of the voting has

Scandion Oncology announces change to its Board of Directors

Thomas Feldthus will step down from the Board of Directors.Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, announces an immediate change to its Board of Directors. Thomas Feldthus, a member of the Board of Directors since 2018 and Chairman of the Audit Committee, will step down due to other professional commitments. Having recently taken the position of CEO of Saniona, Thomas Feldthus needs to free up time for this operational role. “Thomas Feldthus has been a valued member of

SMART WIRES CEO LEADS DISCUSSION WITH ENERGY LEADERS ABOUT GETS AND POLICY SHAPING THE INDUSTRY

Conversation with FERC Commissioner Allison Clements kicks off day of discussions about grid enhancing technologies, the policy surrounding their integration and their role in the energy transition.Smart Wires leaders led a day of discussions about grid enhancing technology (GET) and policies shaping the energy industry. Smart Wires CEO Peter Wells interviewed Federal Energy Regulatory Commission (FERC) Commissioner Allison Clements at DISTRIBUTECH International 2022  on May 23 in Dallas, Texas. The conversation headlined the WATT Coalition’s Grid Enhancing

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 25.05.2022

Fiskars Corporation   Stock Exchange Release 25.05.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 25.05.2022   Date 25.05.2022  Exchange transaction Buy  Share class FSKRS  Amount  2,622  Average price/share 18.8104 EURHighest price/share 19.0800 EURLowest price/share 18.5400 EURTotal price 49,320.87 EUR        The shares held by Fiskars Corporation on 25.05.2022:   FSKRS 666,052       On

Bulletin from Annual General Meeting in Tobii AB (publ) on May 25, 2022

The following resolutions were passed at the Annual General Meeting in Tobii AB (publ) on May 25, 2022. The Annual General Meeting was carried out through advance voting only, without the physical presence of shareholders, proxies and third parties. The Annual General Meeting resolved in accordance with all proposals submitted by the Board of Directors and the Nomination Committee. Approval of the annual report, appropriation of result and discharge from liabilityThe Annual General Meeting resolved to adopt the income statement and balance sheet, consolidated income statement and

Relesys realizes 33% year-over-year growth in Annual Recurring Revenue in Q1 2022.

Relesys A/S | Quarterly Announcement Q1 2022 Company Announcement No. 6-2022Copenhagen, May 25[th], 2022 First-quarter period: 1 January 2022 - 31 March 2022 Relesys achieved an Annual Recurring Revenue (ARR) of DKKm 33.8 and is starting the year in accordance with the plan. Current financial guidance is kept unchanged.   Summary: Relesys started 2022 by executing on the strategy presented in the IPO Prospectus from December 2021. During Q1 Relesys increased its sales efforts by hiring 15 new colleagues in Sales and Marketing. As such Q1 was a quarter for welcoming and

An accident at the production plant of Metsä Tissue Krapkowice Sp. z o. o.

On May 25, 2022, at 2:00 p.m., an accident took place at the production plant of Metsä Tissue Krapkowice sp. z o. o. The accident happened in the Paper Machines area during maintenance work and concerned three employees of the Maintenance Department. The accident was caused by leakage of steam.                                                     An ambulance, fire brigade and police were called to the scene. The victims were receiving medical attention. No material damage was caused to the mill premises. More information: VP Production, Paweł Ehrlich, pawel.ehrlich@metsagroup.

Svenska Aerogel Holding AB (publ) at exhibition in the United States – marketing Quartzene’s® benefits for Cool Roof solutions

In April, Svenska Aerogel Holding AB participated in the American Coatings Show, in collaboration with distributor Van Horn, Metz & Co. The exhibition, which takes place in Indianapolis, is the leading North American event in the coatings industry. Here, Svenska Aerogel was able to inform several manufacturers about how Quartzene® benefits Cool Roof solutions.[En bild som visar text, person, stående Automatiskt genererad beskrivning] Joakim Wanner, Sales Director at Svenska Aerogel, together with Barrett C. Fisher, President and CEO of VHM.   This year’s exhibition was the first

Faster, Better, Stronger: REPowerEU plan reveals how the energy transition must happen

Faced with two urgent matters, the conflict in Ukraine and the climate crisis, the people and the industry want a faster and a just energy transition to reduce dependency on fossil fuels and fight climate change. So, the policymakers are taking action to create a roadmap. To this end, the European Commission announced its REPowerEU plan on May 18th, 2022. The plan moves the deadline for the many energy transition goals from 2030 to before 2027.  REPowerEU brings in the forceThe Commission announced the steps and measures to facilitate the transition. The three main steps to be taken

Saga Pure ASA – share capital increase registered

Reference is made to the stock exchange announcement on 13 May 2022 regarding a decision by the Board of Directors of Saga Pure ASA ASA to increase the share capital following exercise of share options. The share capital increase has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 10,000 through issuance of 1,000,000 new shares, each with a par value of NOK 0.01. The new share capital is thus NOK 4,798,784.23 divided by 479,878,423 shares, each with a par value of NOK 0.01. For further information please contact:

The Board of Directors of Betolar Plc Resolved on Incentive Plans for Key Employees

Betolar Plc                Company Release 25.5.2022 at 4:30 PM EET The Board of Directors of Betolar Plc Resolved on Incentive Plans for Key Employees The Board of Directors of Betolar Plc has resolved on two new share-based incentive plans for the key employees of the group. The purpose of the plans is to align the objectives of the shareholders and the key employees in order to increase the value of the company in the long-term, as well as to ensure retention of the key employees in the company and offer them competitive incentive plans.   The Stock Option Plan The

Relais Group Plc – Managers' Transactions

Relais Group Plc – Managers' TransactionsRelais Group Plc, Company Release 25.5.2022 at 16:30 EET Person subject to the notification requirementName: Olli-Pekka KallasvuoPosition: Member of the Board/Deputy member Issuer: Relais Group OyjLEI: 743700X9S8FVYRI20J88Notification type: INITIAL NOTIFICATIONReference number: 15523/4/6 ____________________________________________ Transaction date: 2022-05-20Venue not applicableInstrument type: SHAREISIN: FI4000391487Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programme Transaction details(

Relais Group Plc – Managers' Transactions

Relais Group Plc – Managers' TransactionsRelais Group Plc, Company Release 25.5.2022 at 16:30 EET Person subject to the notification requirementName: Katri NygårdPosition: Member of the Board/Deputy member Issuer: Relais Group OyjLEI: 743700X9S8FVYRI20J88Notification type: INITIAL NOTIFICATIONReference number: 15525/5/12 ____________________________________________ Transaction date: 2022-05-23Venue not applicableInstrument type: SHAREISIN: FI4000391487Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programme Transaction details(1):

BeammWave granted a joint project with KTH and Lund University from Vinnova

The project is coordinated by BeammWave and has a total budget of MSEK 7.6 whereas the Vinnova grant, under the call “Smartare Elektroniksystem” is MSEK 3.8 and the BeammWave share of the grant has a total of MSEK 1.1.The project title is “Low complexity MIMO mmWave transceiver architectures for handheld devices”. It has the objective to take BeammWave from a patented design and prototype to a validated production-ready product, and thus enable collaboration with commercial actors.   "The collaboration with KTH, Royal Institute of Technology and Lund University brings tremendous value

There are no items matching the current filter
There are no more items matching the current filter
Back to top